Vitamin D3 mediates amelioration of ulcerative colitis via the TRPV1-MAPK signaling pathway

Key Points

• Vitamin D3 plays a protective role in ulcerative colitis, improving immune responses and barrier function.
• The study identifies the TRPV1-MAPK signaling pathway as a crucial mediator for the effects of vitamin D3.
• Assessment highlights the potential of vitamin D3 in treatment strategies for ulcerative colitis.
• Further exploration may validate the therapeutic applications of vitamin D3, especially in clinical settings.